Suely Meireles Rezende

Universidade Federal de Minas Gerais — Brazil

Medicine · Health Sciences

17h-index1.8kcitations142works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(54), Hemophilia Treatment and Research(47), Blood Coagulation and Thrombosis Mechanisms(29), Platelet Disorders and Treatments(24), Cancer-related gene regulation(14)

Publications142 total

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Sustainable anticoagulation for climate resilient care
The Lancet Haematology·2025
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis
Thrombosis Research·2025· 1 cited
Longitudinal Evaluation of Immunological Biomarkers in Previously Untreated/Minimally Treated Patients With Severe and Moderately Severe Haemophilia A During Exposure to Factor VIII: Results From the HEMFIL Study
Haemophilia·2025Open Access
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study
Thrombosis Research·2025
Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations
Blood Advances·2025Open Access
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model
Research and Practice in Thrombosis and Haemostasis·2024Open Access
HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group
Hematology Transfusion and Cell Therapy·2024Open Access
Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort
Hematology Transfusion and Cell Therapy·2024Open Access
Incidence of venous thromboembolism and adequacy of thromboprophylaxis in 2380 acutely-ill hospitalized patients: Results from the PROFMiG cohort study
Thrombosis Research·2024
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors
Thrombosis Research·2024· 3 cited
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
Journal of Thrombosis and Haemostasis·2024· 37 citedOpen Access
Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately severe hemophilia A using a machine-learning network
Journal of Thrombosis and Haemostasis·2024· 7 cited
High levels of anti–factor VIII immunoglobulin G4 and immunoglobulin G total are associated with immune tolerance induction failure in people with congenital hemophilia A and high-responding inhibitors
Research and Practice in Thrombosis and Haemostasis·2024· 2 citedOpen Access
Hypocoagulability in severe yellow fever infection is associated with bleeding: results from a cohort study
Research and Practice in Thrombosis and Haemostasis·2024· 1 citedOpen Access
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice
Blood Advances·2024· 2 citedOpen Access
Electrocardiographic Findings Among Asymptomatic Adults With Haemophilia
International Journal of Cardiovascular Sciences·2024Open Access
Native American Ancestry Is Associated with Successful Immune Tolerance Induction in Admixed Brazilians with Hemophilia a
Blood·2023
Levels of Anti-FVIII IgG4 and Total IgG Are Biomarkers of Immune Tolerance Induction Failure in Patients with Inherited Hemophilia a and High-Responding Inhibitors
Blood·2023
Large Deletion in the Factor VIII Gene Is a Predictor of Immune Tolerance Induction Failure in People with Severe and Moderately-Severe Hemophilia a and High-Responding Inhibitors
Blood·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Letícia Lemos Jardim(10), Daniel Gonçalves Chaves(7), Holger J. Schünemann(6), Ignacio Neumann(6), Camila Caram‐Deelder(6), Johanna G. van der Bom(6), Samantha C. Gouw(5), Sandhi Maria Barreto(5), Ricardo Mesquita Camelo(5), Mary Cushman(4), Kenneth A. Bauer(4), Frits R. Rosendaal(4), Ariel Izcovich(4), M. Cerqueira(4), Claúdia Santos Lorenzato(4), Vivian Karla Brognoli Franco(4), Luciana W. Zuccherato(4), Susan R. Kahn(3), Frederick A. Spencer(3), Wojtek Wiercioch(3)